Amelioration of insulin resistance by rosiglitazone is associated with increased adipose cell size in obese type 2 diabetic patients.
about
Glucose dysregulation and response to common anti-diabetic agents in the FATZO/Pco mouse.Adipose Cell Size and Regional Fat Deposition as Predictors of Metabolic Response to Overfeeding in Insulin-Resistant and Insulin-Sensitive Humans.Comparative analysis of three human adipocyte size measurement methods and their relevance for cardiometabolic risk.
P2860
Amelioration of insulin resistance by rosiglitazone is associated with increased adipose cell size in obese type 2 diabetic patients.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Amelioration of insulin resist ...... bese type 2 diabetic patients.
@ast
Amelioration of insulin resist ...... bese type 2 diabetic patients.
@en
type
label
Amelioration of insulin resist ...... bese type 2 diabetic patients.
@ast
Amelioration of insulin resist ...... bese type 2 diabetic patients.
@en
prefLabel
Amelioration of insulin resist ...... bese type 2 diabetic patients.
@ast
Amelioration of insulin resist ...... bese type 2 diabetic patients.
@en
P2093
P2860
P356
P1433
P1476
Amelioration of insulin resist ...... bese type 2 diabetic patients.
@en
P2093
Arthur S Sherman
Samuel W Cushman
Shawn Mullen
P2860
P304
P356
10.4161/ADIP.34425
P577
2014-10-01T00:00:00Z